ESC 365 - Combined class I and class III antiarrhythmic effects of sotagliflozin - insights from heterologous expressions systems and atrial cardiomyocytes

Back

ESC Professional Premium Access

Combined class I and class III antiarrhythmic effects of sotagliflozin - insights from heterologous expressions systems and atrial cardiomyocytes

Session: Novel insights into arrhythmias

Topic: Ion Channels, Electrophysiology

Speaker: Mr L. Weirauch (Heidelberg, DE)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Mr Leo Weirauch

Heidelberg (Germany)

0 follower

8 more presentations in this session

Efficacy and safety of HERG channel agonists for treatment of Long QT Syndrome type 8

Speaker: Doctor D. Kukavica (Pavia, IT)

Characterisation of the novel SCN5A-P1891A variant, implicated in left ventricular noncompaction cardiomyopathy in a Finnish family, using human induced pluripotent stem cell-derived cardiomyocytes.

Speaker: Doctor Q. Majid (Helsinki, FI)

Advancing cardiac 3D organoid-on-chip: integrating iPSC-derived MELAS syndrome models to study electromechanical synchronicity and cardiac memory using contactless technology

Speaker: Associate Professor M. Miragoli (Parma, IT)

Investigating the role of WT1 in Brugada syndrome pathophysiology

Speaker: Ms M. Marsman (Amsterdam, NL)

Computational modeling of cardiac electrophysiology applied to a swine model of Long QT Syndrome

Speaker: Doctor A. Trancuccio (Pavia, IT)

Access the full session

Novel insights into arrhythmias

Speakers: Mr L. Weirauch, Doctor D. Kukavica, Doctor Q. Majid, Associate Professor M. Miragoli, Ms M. Marsman...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources